VF
YTEN

Virtu Financial’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History

Virtu Financial’s Portfolio YTEN Stock Details YTEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,506
Closed -$9K – 2334
2023
Q4 		$9K Buy
1,506
+866
+135% +$5.75K ﹤0.01% 1426
2023
Q3 		$5K Buy
+640
New +$16.1K ﹤0.01% 1155
2022
Q4 		– Sell
-659
Closed -$47K – 2301
2022
Q3 		$47K Buy
+659
New +$44.5K ﹤0.01% 1219
2020
Q3 		– Sell
-427
Closed -$64K – 1639
2020
Q2 		$64K Buy
+427
New +$58.2K 0.01% 970
2019
Q4 		$57K Buy
+344
New +$109K 0.01% 1187
2019
Q3 		– Sell
-19
Closed -$18K – 1937
2019
Q2 		$18K Buy
19
+7
+58% +$6.69K ﹤0.01% 1356
2019
Q1 		$13K Sell
12
-3
-20% -$3.23K ﹤0.01% 1322
2018
Q4 		$12K Buy
+15
New +$18.3K ﹤0.01% 1428
2018
Q3 		– Sell
-27
Closed -$36K – 2347
2018
Q2 		$36K Buy
+27
New +$42.8K ﹤0.01% 1808

Other funds holding YTEN

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
CS
Cannell & Spears New York $5.1B AUM 31.77% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
CCB
Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GWM
Grand Wealth Management Grand Rapids, Michigan $212M AUM 18.89% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Virtu Financial's YTEN Position: Q1 2024 in Review

Virtu Financial sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q1 2024, closing a stake of 1,506 shares — an estimated $9K sold.

Virtu Financial first reported a position in YTEN in Q2 2018 and held it in 9 quarters. The position peaked at $64K in Q2 2020. 19 funds tracked by Wall St. Rank hold YTEN as of Q1 2024.

  • Virtu Financial reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Virtu Financial sold 1,506 Yield10 Bioscience, Inc. Common Stock shares in Q1 2024, an estimated $9K.
  • Virtu Financial first reported a position in Yield10 Bioscience, Inc. Common Stock in Q2 2018 and held it in 9 quarters.
  • Virtu Financial's Yield10 Bioscience, Inc. Common Stock position peaked at $64K in Q2 2020.
  • 19 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q1 2024.

Based on Virtu Financial's 13F filing for Q1 2024, filed 20 May 2024.